Abstract
Upper genital tract infection in women has for years been referred to as pelvic inflammatory disease. This term specifies neither the site nor the type of infection. Unfortunately it has become so ingrained in the literature that it has become common medical vernacular. It is preferable to indicate at least the site of infection by using such terms as endometritis, salpingitis, salpingo-oophoritis, or tubo-ovarian abscess. Since these infections often represent a progression from endometritis to salpingitis and ultimately to pyosalpinx, hydrosalpinx, or tubo-ovarian abscess, it may be difficult to find a term that specifies the type and extent of infection. Further specificity can be achieved by referring to these infections as acute or chronic to indicate the severity and course of the infection.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Eschenbach DA, Harnisch JP, Holmes KK. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol. 1977; 128: 838–850.
Sweet RL. Diagnosis and treatment of acute salpingitis. J Reprod Med. 1977; 19: 21–30.
Westrom L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980; 138: 880–892.
Curran JW. Economic consequences of pelvic inflammatory disease in the United States. Am J Obstet Gynecol. 1980; 138: 848–851.
Jones OG, Saida A A, St. John RK. Frequency and distribution of salpingitis and pelvic inflammatory disease in short stay hospitals in the United States. Am J Obstet Gynecol. 1980; 138: 905–908.
St. John RK, Jones OG, Blount JH. The epidemiology and trend of pelvic inflammatory disease among hospitalized women. Sex Transm Dis. 1981; 8: 62–66.
Westrom L: Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol. 1975; 122: 707–713.
Eschenbach DA, Buchanan T, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med. 1975; 293: 166–71.
Eschenbach DA. Epidemiology and diagnosis of acute pelvic inflammatory disease. Obstet Gynecol. 1980;55:sl42–sl53.
Lip J, Burgoyne X. Cervical and peritoneal bacterial flora associated with salpingitis. Obstet Gynecol. 1966; 28: 561–63.
Sweet RL, Mills, Hadley WK, et al. Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol. 1979; 134: 68–74.
Thompson SE, Hager WD, Wong KH, et al. The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients. Am J Obstet Gynecol. 1980; 136: 179–186.
Cunningham FG, Hauth JC, Gilstrap LC, et al. The bacterial pathogenesis of acute pelvic inflammatory disease. Obstet Gynecol. 1978; 52: 161–164.
Sweet RL. Pelvic inflammatory disease: Etiology, diagnosis and treatment. Sex Transm Dis 1981; 8 (Suppl): 308–315.
Sweet RL, Draper DL, Schachter J, et al. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: What is the appropriate site to sample? Am J Obstet Gynecol. 1980; 138: 985 - 989.
Chow AW, Malkasian KL, Marshall JR, et al. The bacteriology of acute pelvic inflammatory disease. Am J Obstet Gynecol. 1975; 122: 876–879.
Cunningham FG, Hauth JC, Strong JD, et al. Evaluation of tetracycline or penicillin and ampicillin for the treatment of acute pelvic inflammatory disease. N Engl J Med. 1977; 296: 1380–1383.
Mardh P-A, Ripa T, Svensson L, Westrom L. Chlamydia trachomatis infection in patients with acute salpingitis. N Engl J Med. 1977; 298: 1377–1379.
Monif GRG, Welkos SL, Baer H, et al. Culde-sac isolates from patients with endome-tritissalpingitis-peritonitis and gonococcal endocervicitis. Am J Obstet Gynecol. 1976; 126: 158–61.
Sweet RL, Draper D, Hadley WK. Etiology of acute salpingitis: influence of episode number and duration of symptoms. Obstet Gynecol. 1981; 58: 62–68.
Bartlett JG, Onderdonk AB, Drude E, et al. Quantitative bacteriology of the vaginal flora. J Infect Dis. 1977; 136: 271–277.
Larsen B, Galask RP. Vaginal microbial flora: practical and theoretical relevance. Obstet Gynecol. 1980; 55: s100–s113.
McCormack WM, Nowroozi K, Alpert S. Acute pelvic inflammatory disease: characteristics of patients with gonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin-G and spectinomycin hydrochloride. Sex Transm Dis. 1977; 4: 125–131.
Eschenbach DA, Holmes KK. Acute pelvic in-flammatory disease. Current concepts of pathogenesis, etiology and management. Clin Obstet Gynecol. 1975; 18: 35–56.
Studdiford WE, Casper WA, et al. The persistence of gonococcal infections in the adnexa. Surg Gynecol Obstet. 1938; 67: 176–178.
Tronca E, Handsfield HH, Wiesner PJ, Holmes KK. Demonstration of Neisseria gonorrhoeae with fluorescent antibody in patients with disseminated gonococcal infection. J Infect Dis. 1974; 129: 583–586.
Nolan GJ, Osborne N. Gonococcal infection in the female. Obstet Gynecol. 1973; 42: 156–164.
Keith LG, Berger GS, Edelman DA, et al. On the causation of pelvic inflammatory disease. Am J Obstet Gynecol. 1984; 149: 215–224.
Draper DL, Donegan EA, James JF, et al. Scanning electron microscopy of attachment of Neisseria gonorrhoeae colony phenotypes to surfaces of human genital epithelia. Am J Obstet Gynecol. 1980; 138: 818–826.
Draper DL, James JF, Brooks GF, Sweet RL. Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolated from women with acute salpingitis. Infect Immun. 1980; 27 (3): 882–888.
Draper DL, James JF, Hadley WK, Sweet RL. Auxotypes and antibiotic susceptibilities of Neisseria gonorrhoeae from women with acute salpingitis. Sex Transm Dis. 1981; 8 (2): 43–50.
Kellogg DS Jr, Peacock WL Jr, Deacon WE, et al. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J Bacteriol. 1963; 85: 1274–1279.
Kellogg DS Jr, Cohen IR, Norins LC, et al. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol. 1968; 95: 596–605.
Swanson J. Studies on gonococcus infection. XII. Colony color and opacity variants of gonococci. Infect Immun. 1978; 19: 320–321.
James JF, Swanson J. Studies on gonococcal infection. XIII. Occurrence of color/opacity variants in clinical cultures. Infect Immun. 1978; 19: 332–340.
Lambden PR, Heckeis JE, James LT, Watt PJ. Variations in surface protein composition asso-ciated with virulence properties in opacity types of Neisseria gonorrhoeae. J Gen Microbiol. 1979; 114: 305–312.
Lambden PR. Biochemical comparison of pili from variants of Neisseria gonorrhoeae P9. J Gen Microbiol. 1982; 128: 2105–2111.
Lambden PR, Robertson JN, Watt PJ. The preparation and properties of and pili from variants of Neisseria gonorrhoeae P9. J Gen Microbiol. 1981; 124: 109–117.
Lambden PR, Heckels JE, McBride H, Watt PJ. The identification and isolation of novel pilus types produced by variants of Neisseria gonorrhoeae P9 following selection in vivo. FEMS Microbiol Lett. 1981; 10: 339–341.
McDade RL Jr, Johnston KH. Characterization of serologically dominant outer membrane proteins of Neisseria gonorrhoeae. J Bacteriol. 1980; 141: 1183–1191.
Sandstrom EG, Chen KC, Buchanan TM. Se-rology of Neisseria gonorrhoeae: Coagglutination serogroups WI and WII/III correspond to different outer membrane protein I molecules. Infect Immun. 1982; 38: 462–470.
Buchanan TM, Eschenbach DA, Knapp JS, Holmes KK. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigen type. Am J Obstet Gynecol. 1981; 138: 978–981.
Lambden PR, Heckels JE. Outer membrane protein composition and colonial morphology of Neisseria gonorrhoeae strain P9. FEMS Microbial Lett. 1979; 15: 263–265.
Zak K, Diaz J-L, Jackson D, Heckels JE. Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J Infect Dis. 1984; 149: 166–174.
McGee ZA, Stephens DS, Hoffman LH, et al. Mechanisms of mucosal invasion by pathogenic Neisseria. Rev Infect Dis. 1983; 5 (Suppl 4): S708–S714.
McGee ZA, Johnson AP, Taylor-Robinson D. Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or colony type 4. J Infect Dis 1981; 143: 413–422.
Melly MA, Gregg CR, McGee ZA. Studies of toxicity of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis. 1981; 143: 423–431.
Gregg CR, Melly MA, McGee ZA. Gonococcal lipopolysaccharide: a toxin for human fallopian tube mucosa. Am J Obstet Gynecol. 1980; 138: 981–984.
Gregg CR, Melly MA, Mellerquist CG, et al. Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis. 1981; 143: 432–439.
Melly MA, McGee ZA, Rosenthal RS. Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian tube mucosa. J Infect Dis. 1984; 149: 378–386.
Swanson J. Gonococcal adherence: selected topics. Rev Infect Dis. 1983;5(Suppl 4)S678–S684.
Tramont E, Sadoff J, Boslego JW, et al. Gonococcal pilus vaccine studies of antigenicity and inhibition of attachment. J Clin Invest. 1981; 68: 881–888.
Buchanan TM, Siegal MS, Chen KCS, Pearce WA. Development of a vaccine to prevent gonorrhea. Semin Infect Dis. 1982; 4: 160–164.
Moulder JW. The relation of the psittacosis group (chlamydiae) to bacteria and viruses. Annu Rev Microbiol. 1966; 20: 107–130.
Page LA. The ricksettsias. In: Buchanan RE, Gibbons NE, eds. Bergey’s Manual of Determinative Bacteriology, 8th ed. Baltimore: Williams & Wilkins, 1974: 914–918.
Friis RR. Interaction of L cells and chlamydia psittaci: entry of the parasite and host responses to its development. J Bacteriol. 1972; 110: 706–721.
Kuo C-C, Wang S-P, Grayston JT. Effect of polycations, polyanions and neuroaminidase on the infectivity of trachomainclusion conjunctivitis and lymphogranuloma venereum organisms in HeLa cells: sialic acid residues as possible receptors for trachoma-inclusion conjunctivitis. Infect Immun. 1973; 8: 74–79.
Sweet RS, Schachter J, Landers DV. Chlamydial infections in obstetrics and gynecology. Clin Obstet Gynecol. 1983; 26: 143–164.
Richmond SJ, Oriel JD. Recognition and management of genital chlamydial infection. Br Med J. 1978; 2: 480–482.
Schachter J. Chlamydial infections. N Engl J Med. 1978; 298: 428–435.
Osser S, Persson K: Epidemiology and serodiagnostic aspects of chlamydia salpingitis. Obstet Gynecol. 1982; 59: 206–209.
Moller BR, Mardh P-A, Ahrons S, Nussler E: Infections with Chlamydia trachomatis, Mycoplasma hominis and Neisseria gonorrhoeae in patients with acute pelvic inflammatory disease. Sex Transm Dis. 1981; 8: 198–202.
Gjonnaess H, Dalaker K, Anestad G, et al. Pelvic inflammatory disease: etiologic studies with emphasis on chlamydial infection. Obstet Gynecol. 1982; 59: 550–555.
Ripa KT, Svensson L, Treharne JD, et al. Chlamydia trachomatis infection in patients with laparoscopically verified salpingitis: results of isolation and antibody determinations. Am J Obstet Gynecol. 1980; 138: 960–964.
Mardh P-A, Lind I, Svensson L, et al. Antibodies to Chlamydia trachomatis, Mycoplasma hominis and Neisseria gonorrhoeae in sera from patients with acute salpingitis. Br J Vener Dis. 1981; 57; 125–129.
Paavonen J. Chlamydia trachomatis in acute salpingitis. Am J Obstet Gynecol. 1980; 138: 957–959.
Paavonen J, Saikku P, Vesterinen E, Aho K. Chlamydia trachomatis in acute salpingitis. Br J Vener Dis. 1979; 55: 203–206.
Eilard T, Brorsson J-E, Hamark B, Forssman L. Isolation of chlamydia in acute salpingitis. Scand J Infect Dis (Suppl). 1976; 9: 82–84.
Schachter J, Banks J, Sung M, Sweet R. Hydrosalpinx as a consequence of chlamydia salpingitis in the guinea pig. In: Mardh P-A, Holmes KK, Oriel JD, et al, eds. Chlamydial infections. Amsterdam: Elsevier Biomedical Press, 1982.
Svensson L, Westrom L, Ripa KT, Mardh P-A. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic findings. Am J Obstet Gynecol. 1980; 138: 1017–1021.
Sweet RL, Schachter J, Robbie MO. Failure of betalactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA. 1983; 250: 2641–2645.
Punnonen R, Terho P, Nikkanen V, Meurman O. Chlamydial serology in infertile women by immunofluorescence. Fertil Steril. 1979; 31: 656–659.
Henry-Suchet J, Catalan F, Loffredo V, et al. Microbiology of specimens obtained by laparoscopy from controls and from patients with pelvic inflammatory disease or infertility with tubal obstruction: Chlamydia trachomatis, Ureaplasma urealyticum. Am J Obstet Gynecol. 1980; 138: 1022–1025.
Jones RB, Ardery BR, Hui SL, et al. Correlation between serum antichlamydial antibodies and tubal factors as a cause of infertility. Fertil Steril. 1982; 38: 553–555.
Moore DE, Spadodni LR, Roy HM, et al. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tube disease. Lancet. 1982; 2: 574–577.
Gump DW, Gibson M, Ashikaga T. Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women. Am J Obstet Gynecol. 1983; 146: 153–159.
Gibson M, Gump D, Ashsikaga T, Hall B. Patterns of adnexal inflammatory damage: Chlamydia, the intrauterine device and history of pelvic inflammatory disease. Fertil Steril. 1984; 41: 47–51.
Cevenini R, Possati G, LaPlaca M. Chlamydia trachomatis infection in infertile women. In: Mardh P-A, Holmes KK, Oriel JD, et al, eds. Chlamydia Infections. Amsterdam: Elsevier Biomedical Press, 1982: 189–192.
Patton DL, Haibert SA, Kuo C-C, et al. Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys. Fertil Steril. 1983; 40: 829–840.
Ripa KT, Moller BR, Mardh P-A, et al. Experimental acute salpingitis in grivet monkeys provoked by Chlamydia trachomatis. Acta Pathol Microbiol Scand. 1979; 87: 65–69.
Rank RS, White HJ, Barron AL. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun. 1979; 26: 573–579.
White HJ, Rank RS, Soloff BL, Barron AL. Experimental chlamydial salpingitis in immunosuppressed guinea pigs infected in the genital tract with agents of guinea pig inclusion conjunctivitis. Infect Immun. 1979; 26: 728–735.
Sweet RL, Schachter J, Banks J, Sung M. Experimental chlamydial salpingitis in the guinea pig. Am J Obstet Gynecol. 1980; 138: 952–956.
Moller BR, Westrom L, Ahrons S, et al. Chlamydia trachomatis infection of the fallopian tubes: histologic findings in two patients. Br. J Vener Dis. 1979; 55: 422–428.
Swenson CE, Donegan E, Schachter J. Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis. 1983; 148: 1101–1107.
Swenson CE, Schachter J. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice. Sex Transm Dis. 1984; 11: 64–67.
Muller-Schoop JW, Wang SP, Munzinger J, et al. Chlamydia trachomatis as a possible cause of peritonitis and perihepatitis in young women. Br Med J. 1978; 1: 1022–1024.
Wolner-Hansson P, Westrom L, Mardh P-A. Perihepatitis in chlamydial salpingitis. Lancet. 1980; 1: 901–904.
Paavonen J, Saikku P, Von Knorring J, et al. Association of infection with Chlamydia trachomatis with Fitz-Hugh-Curtis syndrome. J Infect Dis. 1981; 144: 176.
Wang SP, Eschenbach DA, Holmes KK, et al. Chlamydia trachomatis infection in Fitz-Hugh- Curtis syndrome. Am J Obstet Gynecol. 1980; 138: 1034–1038.
Moller BR, Mardh P-A. Experimental acute salpingitis in grivet monkey by Chlamydia trachomatis. Acta Pathol Microbiol Scand. 1980; 88: 107–114.
Mardh P-A, Lind I, Svensson L, et al. Antibodies to Chlamydia trachomatis, Mycoplasma hominis and Neisseria gonorrhoeae in sera from patients with acute salpingitis. Br J Vener Dis. 1981; 57: 125–129.
March P-A, Westrom L. Tubal and cervical cultures in acute salpingitis with special reference to Mycoplasma hominis and T-strain mycoplasma. Br J Vener Dis. 1970; 46: 179–186.
Collier A. Attachment by mycoplasms and its role in disease. Rev Infect Dis. 1983; 5 (Suppl 4): S685–S691.
Mardh P-A, Westrom L, Ripa KT, Moller BR. Pelvic inflammatory disease: clinical, etiologic and pathophysiologic studies. In: Holmes KK, Mardh P-A, eds. International perspectives on neglected sexually transmitted diseases. New York: Hemisphere Publishing Co., 1983: 251–268.
Moller BR, Freundt EA, Mardh P-A. Experimental pelvic inflammatory disease provoked by Chlamydia trachomatis and Mycoplasma hominis in grivet monkeys. Am J Obstet Gynecol. 1980; 138: 990–995.
Sweet RL, Robbie MO, Ohm-Smith M, Hadley WK. Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol. 1983; 145: 342–349.
Gall SA, Kohan MT, Ayers OM, et al. Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections. Obstet Gynecol. 1981; 57: 51–58.
Sweet RL. Unpublished data.
Kirby BD, George WL, Sutter VL, et al. Gram-negative anaerobic bacilli: their roles in infection and patterns of susceptibility to antimicrobial agents. I. Little known Bacteroides species. Rev Infect Dis. 1980; 2: 914–951.
Snydman DR, Tally FP, Knüppel R, et al. Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities. J Antimicrob Chemother. 1980; 6: 519–525.
Gall SA, Addison WA, Hill GB. Moxalactam therapy for obstetric and gynecologic infections. Rev Infect Dis. 1982; 4 (Suppl): S701–S706.
Gibbs RS Blanco JD St. Clair PJ Castaneda YS Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis. 1982; 145: 1–8.
Sweet RL. Treatment of mixed aerobic-anaerobic infections of the female genital tract. J Antimicrob Chemother. 1981; 8 (Suppl D): 105–114.
Joiner K, Lowe B, Dzink J, Bartlett JG. Comparative efficacy of ten antimicrobial agents in experimental Bacteroides fragilis infections. J Infect Dis. 1982; 145: 561–568.
Bartlett JG, Louie TJ, Gorbach SL, Onderdonk AB. Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. Rev Infect Dis. 1981; 3: 535–542.
Ledger WJ. Selection of antimicrobial agents for treatment of infections of the female genital tract. Rev Infect Dis. 1983; 5 (Suppl): S98–S104.
diZerega G, Yonekura L, Roys S, et al. A com-parison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of postcesarean section endomyometritis. Am J Obstet Gynecol. 1979; 134: 238–242.
Hare MJ, Barnes CFJ. Fallopian tube culture in the investigation of Bacteroides as a cause of pelvic inflammatory disease. In: Phillips I, Collier J, eds. Proceedings of the 2nd International Symposium on Metronidazole. London, The Royal Society of Medicine, 1979; 191–198.
Hammill HA, Owens WE, Ford LE, Finegold SM. A rat model of unilateral utero-tubo-ovarian abscess. Rev Infect Dis. 1984; 6 (Suppl 1): S96–S100.
Landers DV, Sweet RL. Tubo-ovarian abscess: Contemporary approach to management. Rev Infect Dis. 1983; 5: 876–884.
Swenson RM, Michaelson TC, Daly MJ, et al. Anaerobic bacterial infections of the female genital tract. Obstet Gynecol. 1973; 42: 538–541.
Altemeier WA. The anaerobic streptococci in tubo-ovarian abscess. Am J Obstet Gynecol. 1940; 39: 1038–1042.
Thadepalli H, Gorbach SL, Keith L. Anaerobic infections of the female genital tract: bacteriologic and therapeutic aspects. Am J Obstet Gynecol. 1973; 117: 1034–1040.
Ledger WJ, Campbell C, Willson JR. Postoperative adnexal infections. Obstet Gynecol. 1968; 31: 83–89.
Pearson HE, Anderson GV. Genital bacteroidal abscesses in women. Am J Obstet Gynecol. 1970; 107: 1264–1265.
Weinstein WM, Onderdonk AB, Bartlett JG, Gorbach SL. Experimental intra-abdominal abscess in rats: development of an experimental model. Infect Immun. 1974; 10: 1250–1255.
Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. The capsular polysaccharide of B. fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977; 136: 82–89.
Kasper DL, Onderdonk AB, Cabb J, Bartlett JG. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis. 1979; 140: 724–731.
Onderdonk AB, Markham RG, Zaleznik DF, et al. Evidence of T-cell-dependent immunity to Bacteroides fragilis in an intra-abdominal abscess model. J Clin Invest. 1982; 69: 9–16.
Washington AE, Catkes W Jr., Zaidi AA. Hos-pitalization for pelvic inflammatory disease. JAMA. 1984; 251: 2529–2533.
Flesh G, Weiner JM, Corlett RC, et al. The intrauterine contraceptive device and acute salpingitis. Am J Obstet Gynecol. 1979; 135: 402–408.
Kaufman DW, Shapiro S, Rosenberg L, et al. Intrauterine contraceptive device use and pelvic inflammatory disease. Am J Obstet Gynecol. 1980; 136: 159–162.
Ory HW. A review of the association between intrauterine devices and pelvic inflammatory disease. J Reprod Med. 1978; 20: 200–204.
Westrom L, Bengtsson LP, Mardh P-A. The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non-users. Lancet. 1976; 2: 221–224.
Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol. 1983; 62: 1–6.
Burnhill MS. Syndrome of progressive endometritis associated with intrauterine contraceptive devices. Adv Planned Parenthood 1973; 8: 144–150.
Sparks RA, Purrier BGA, Watt PJ, Ectein M. Bacterial colonization of uterine cavity: role of tailed intrauterine contraceptive device. Br Med J 1981; 282: 1189–1191.
Skangalis M, Mahoney CJ, O’Leary WM. Microbial presence in the uterine cavity as affected by varieties of intrauterine contraceptive devices. Fertil Steril. 1982; 37: 263–269.
Egli G, Newton M. The transport of carbon particles in the human female reproductive tract. Fertil Steril. 1961; 12: 151–154.
Toth A, O’Leary WM, Ledger W. Evidence for microbial transfer by spermatozoa. Obstet Gynecol. 1982; 59: 556–559.
Street DA, Wells C, Taylor-Robinson D, Ackers JP: Interaction between Trichomonas vaginalis and other pathogenic microorganisms of the human genital tract. Br J Vener Dis. 1984; 60: 31–38.
Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol. 1969; 105: 1088–1098.
Chaparro MV, Ghosh S, Nashed A, et al. Laparoscopy for the confirmation and prognostic evaluation of pelvic inflammatory disease. Int J Gynecol Obstet. 1978; 15: 307–309.
Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol. 1983; 61: 113–114.
Falk V. Treatment of acute non-tuberculous salpingitis with antibiotics alone and in combination with glucocorticoids. Acta Obstet Gynecol Scand. 1965; 44 (Suppl): 1–118.
Hedberg E, Anberg A. Gonorrheal salpingitis: Views on treatment and prognosis. Fertil Steril. 1965; 16: 125–129.
Sweet RL. Unpublished data.
Joiner KA, Lowe BR, Dzink JL, Bartlett JG. Antibiotic levels in infected and sterile subcutaneous abscesses in mice. J Infect Dis. 1981; 143: 487–494.
Joiner KA, Lowe BR, Dzink JL, Bartlett JG. Comparative efficacy of 10 antimicrobial agents in experimental Bacteroides fragilis infections. J Infect Dis. 1982; 145: 561–568.
Ginsberg DS, Stern JL, Hamod KA, et al. Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol. 1980; 138: 1055–1058.
Franklin EW, Hevron JE, Thompson JD. Management of the pelvic abscess. Clin Obstet Gynecol. 1973; 16: 66–79.
Rubin GL, Ory HW, Layde PM. Oral contraceptives and pelvic inflammatory disease. Am J Obstet Gynecol. 144: 630–635.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Landers, D.V., Sweet, R.L. (1986). Upper Genital Tract Infections. In: Galask, R.P., Larsen, B. (eds) Infectious Diseases in the Female Patient. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4852-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4852-1_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-9330-9
Online ISBN: 978-1-4612-4852-1
eBook Packages: Springer Book Archive